News

Learn more about Portal's innovative primary container from our partner, Gerresheimer.

Jay Sparks, host of Finding Unique Value podcast, chats with Patrick Anquetil, CEO and co-founder of Portal Instruments, about how he leveraged his unique science and business background to create value and solve an unmet need with potential to help millions of people.

LEO Pharma and Portal Instruments today announced a global collaboration and license agreement to develop Portal’s innovative needle-free drug delivery system for use in combination with LEO Pharma’s portfolio of investigational and approved medicines.

At Portal, we have taken deliberate steps to identify and “de-risk” the process of partnering with us, from a technical perspective.

Portal Instruments is delighted to be showcasing the latest developments in its connected, needle-free drug delivery platform at PODD 2019 in Boston on October 7-8th, 2019.

The BIO International Convention attracts over 16,000 biotechnology and pharma leaders for one week of intensive networking to discover new opportunities and promising partnerships.

In the final part of our blog series, we look at how the industry is embracing value-based pricing and the role a connected delivery device can play.

In the second part of our blog series, we explore how the ability to measure adherence can give pharmaceutical companies the wherewithal to drive revenue growth.

What can a pharmaceutical firm do to sustainably grow revenue and margins? Read the first article of our three-part blog series to find out more.

We are pleased to share some of our recent news with you. We hope we see you at BIO in Philadelphia in June and at Drug Delivery West in San Francisco in May.